In subsequent research, Transient Receptor Potential Melastatin 3 (TRPM3) cell surface expression was investigated and found to be significantly reduced on the surface of NK cells isolated from ME/CFS patients compared with HCs (34). This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.